- Home
- GLSI vs NSLR Comparison
GLSI vs NSLR Comparison
Compare GLSI & NSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$12.98
Company Overview
Basic Information| Metric | GLSI | NSLR |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.6M | 307.4M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GLSI | NSLR |
|---|---|---|
| Price | $12.98 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 195.1K | ★ 308.6K |
| Earning Date | 05-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.78 | $10.13 |
| 52 Week High | $34.10 | $12.19 |
Technical Indicators
Market Signals| Indicator | GLSI | NSLR |
|---|---|---|
| Relative Strength Index (RSI) | 28.27 | 30.48 |
| Support Level | $8.19 | N/A |
| Resistance Level | $14.19 | $11.62 |
| Average True Range (ATR) | 1.97 | 0.55 |
| MACD | -0.56 | -0.11 |
| Stochastic Oscillator | 5.98 | 0.00 |
Price Performance
Historical Comparison GLSI
NSLR
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.